AC Immune finds new antibodies targeting neurodegenerative diseases

Swiss clinical stage biopharmaceutical company AC Immune has discovered new antibodies against two targets, Alpha-synuclein and TDP-43, in the pathogenesis of neurodegenerative diseases.
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news